Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 21, 2020 - Issue 10: Anti-Hypertensive Pharmacotherapy
Submit an article Journal homepage
594
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluation

An evaluation of empagliflozin and it’s applicability to hypertension as a therapeutic option

Lakshini Y Herata Dobney Hypertension Centre, School of Biomedical Science - Royal Perth Hospital Unit, University of Western Australia, Perth, AustraliaView further author information
,
Vance B Matthewsa Dobney Hypertension Centre, School of Biomedical Science - Royal Perth Hospital Unit, University of Western Australia, Perth, AustraliaView further author information
,
Aaron L Magnob Research Centre, Royal Perth Hospital, Perth, AustraliaView further author information
,
Marcio G Kiuchic Dobney Hypertension Centre, School of Medicine, Royal Perth Hospital Unit, University of Western Australia, Perth, AustraliaORCID Iconhttps://orcid.org/0000-0002-1155-8590View further author information
ORCID Icon,
Revathy Carnagarinc Dobney Hypertension Centre, School of Medicine, Royal Perth Hospital Unit, University of Western Australia, Perth, AustraliaView further author information
&
Markus P Schlaichc Dobney Hypertension Centre, School of Medicine, Royal Perth Hospital Unit, University of Western Australia, Perth, Australia;d Department of Cardiology and Department of Nephrology, Royal Perth Hospital, Perth, AustraliaCorrespondence[email protected]
View further author information
Pages 1157-1166 | Received 03 Nov 2019, Accepted 01 Apr 2020, Published online: 17 Apr 2020

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Omar Azzam, Revathy Carnagarin, Leslie Marisol Lugo-Gavidia, Janis Nolde, Vance B. Matthews & Markus P. Schlaich. (2021) Bexagliflozin for type 2 diabetes: an overview of the data. Expert Opinion on Pharmacotherapy 22:16, pages 2095-2103.
Read now

Articles from other publishers (3)

Fahad M. Althobaiti, Safaa M. Alsanosi, Alaa H. Falemban, Abdullah R. Alzahrani, Salma A. Fataha, Sara O. Salih, Ali M. Alrumaih, Khalid N. Alotaibi, Hazim M. Althobaiti, Saeed S. Al-Ghamdi & Nahla Ayoub. (2022) Efficacy and Safety of Empagliflozin in Type 2 Diabetes Mellitus Saudi Patients as Add-On to Antidiabetic Therapy: A Prospective, Open-Label, Observational Study. Journal of Clinical Medicine 11:16, pages 4769.
Crossref
Atsushi Tanaka & Koichi Node. (2021) Hypertension in diabetes care: emerging roles of recent hypoglycemic agents. Hypertension Research 44:8, pages 897-905.
Crossref
Richard Mprah, Gabriel Komla Adzika, Yusif I. Gyasi, Marie Louise Ndzie Noah, Joseph Adu-Amankwaah, Adebayo O. Adekunle, Maxwell Duah, Prosperl Ivette Wowui & Qiao Weili. (2021) Glutaminolysis: A Driver of Vascular and Cardiac Remodeling in Pulmonary Arterial Hypertension. Frontiers in Cardiovascular Medicine 8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.